Gain-of-function mutations of NLRP3 result in abnormal activation of the NLRP3 inflammasome and cause the autosomal dominant systemic autoinflammatory disease spectrum, termed cryopyrin-associated periodic syndromes (CAPS). Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.